Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Development (Cambridge, England)
|
June 18, 2004
FGF signaling is required for initiation of feather placode development
Markus Mandler, Annette Neubüser
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 12, 2015
Active immunization therapies for Parkinson's disease and multiple system atrophy
Achim Schneeberger, Lanay Tierney, Markus Mandler
Human Vaccines
|
October 29, 2010
AFFITOME® technology in neurodegenerative diseases: the doubling advantage
Achim Schneeberger, Markus Mandler, Frank Mattner, et al.
Genes & Development
|
November 19, 2002
Nephric lineage specification by Pax2 and Pax8
Maxime Bouchard, Abdallah Souabni, Markus Mandler, et al.
Vaccines
|
June 25, 2026
A Case Report of a Novel Alpha-Synuclein Vaccine (TRB-001) in a Parkinson's Patient: Safe Administration and Induction of a High-Titer, High-Avidity Functional Antibody Response
Dieter Volc, Caroline Thun-Hohenstein, Sabine Schmidhuber, et al.
Plos One
|
February 11, 2025
WISIT vaccines based on IL-31-derived peptides as a novel therapeutic approach for chronic pruritic dermatoses
Sabine Schmidhuber, James Dickie, Mihály Cserepes, et al.
Pharmaceutics
|
January 21, 2022
Effect of mRNA Delivery Modality and Formulation on Cutaneous mRNA Distribution and Downstream eGFP Expression
Aditya R Darade, Maria Lapteva, Thomas Hoffmann, et al.
Journal of Neuroinflammation
|
August 16, 2015
Active immunization against complement factor C5a: a new therapeutic approach for Alzheimer's disease
Christine Landlinger, Lisa Oberleitner, Petra Gruber, et al.
Journal of Alzheimer'S Disease : JAD
|
November 9, 2011
Detection of peri-synaptic amyloid-β pyroglutamate aggregates in early stages of Alzheimer's disease and in AβPP transgenic mice using a novel monoclonal antibody
Markus Mandler, Edward Rockenstein, Kiren Ubhi, et al.
Plos One
|
January 23, 2015
Tailoring the antibody response to aggregated Aß using novel Alzheimer-vaccines
Markus Mandler, Radmila Santic, Petra Gruber, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Development (Cambridge, England)
|
June 18, 2004
FGF signaling is required for initiation of feather placode development
Markus Mandler, Annette Neubüser
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 12, 2015
Active immunization therapies for Parkinson's disease and multiple system atrophy
Achim Schneeberger, Lanay Tierney, Markus Mandler
Human Vaccines
|
October 29, 2010
AFFITOME® technology in neurodegenerative diseases: the doubling advantage
Achim Schneeberger, Markus Mandler, Frank Mattner, et al.
Genes & Development
|
November 19, 2002
Nephric lineage specification by Pax2 and Pax8
Maxime Bouchard, Abdallah Souabni, Markus Mandler, et al.
Vaccines
|
June 25, 2026
A Case Report of a Novel Alpha-Synuclein Vaccine (TRB-001) in a Parkinson's Patient: Safe Administration and Induction of a High-Titer, High-Avidity Functional Antibody Response
Dieter Volc, Caroline Thun-Hohenstein, Sabine Schmidhuber, et al.
Plos One
|
February 11, 2025
WISIT vaccines based on IL-31-derived peptides as a novel therapeutic approach for chronic pruritic dermatoses
Sabine Schmidhuber, James Dickie, Mihály Cserepes, et al.
Pharmaceutics
|
January 21, 2022
Effect of mRNA Delivery Modality and Formulation on Cutaneous mRNA Distribution and Downstream eGFP Expression
Aditya R Darade, Maria Lapteva, Thomas Hoffmann, et al.
Journal of Neuroinflammation
|
August 16, 2015
Active immunization against complement factor C5a: a new therapeutic approach for Alzheimer's disease
Christine Landlinger, Lisa Oberleitner, Petra Gruber, et al.
Journal of Alzheimer'S Disease : JAD
|
November 9, 2011
Detection of peri-synaptic amyloid-β pyroglutamate aggregates in early stages of Alzheimer's disease and in AβPP transgenic mice using a novel monoclonal antibody
Markus Mandler, Edward Rockenstein, Kiren Ubhi, et al.
Plos One
|
January 23, 2015
Tailoring the antibody response to aggregated Aß using novel Alzheimer-vaccines
Markus Mandler, Radmila Santic, Petra Gruber, et al.
Page
of 2